CD8A and Huntington disease: Interestingly, the Discharged and Follow-up groups contributed the majority of CD8A+KLRB1hiCXCR4hi terminal differentiation T subset and CD8A+CD160hi T effector subset (Fig. 5a), in which the Discharged group revealed anti-viral hallmarks by GSEA contrast to HD group (Fig. 5b).